Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring

Charlie Goodwin, President and Chief Executive Officer of Apyx Medical. [...]

By |2023-04-28T13:32:08+00:00April 28, 2023|3rd Party Medical Device Industry News|Comments Off on Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring
Go to Top